10-Q: Jaws Mustang Faces Going Concern Doubt Amid SPAC Deadline

Sentiment:

Quarterly Report


Jaws Mustang Acquisition Corporation reports a net loss for the first half of 2025 and faces substantial doubt about its ability to continue as a going concern without a business combination by September 2025.

Delay expectedThe business combination deadline has been extended multiple times, from an initial February 4, 2023, to the current September 4, 2025, with potential for further extensions until December 4, 2026.Each extension has been accompanied by significant shareholder redemptions, indicating a lack of progress or confidence in finding a suitable target.
Capital raiseThe company has outstanding working capital loans and promissory notes from related parties (Sponsor and affiliates) totaling $1,900,000.An additional advance from related parties of $1,485,000 is disclosed.Up to $1,500,000 of these loans may be convertible into warrants at $2.00 per warrant, at the option of the lender, indicating a potential future equity issuance.
Worse than expectedThe company reported a net loss for the six months ended June 30, 2025, and a significant decrease in operating cash.The working capital deficit has worsened, indicating severe liquidity issues.The delisting from NYSE American to the OTC Pink Open Market is a negative development, signaling a failure to meet exchange requirements and potentially reducing investor interest and liquidity.The substantial doubt about the company's ability to continue as a going concern highlights the precarious financial position.

Summary

  • Jaws Mustang Acquisition Corporation is a blank check company formed to effect a business combination, having not yet commenced operations.
  • The company reported a net loss of $267,778 for the six months ended June 30, 2025, compared to a net loss of $2,818,131 for the same period in 2024.
  • Cash on hand decreased significantly to $38,297 as of June 30, 2025, from $319,207 at December 31, 2024.
  • Cash held in the Trust Account increased slightly to $1,049,122 as of June 30, 2025, from $1,035,353 at December 31, 2024.
  • The company's working capital deficit was $2,819,579 as of June 30, 2025.
  • Total liabilities increased to $5,897,597 as of June 30, 2025, from $5,892,899 at December 31, 2024.
  • Shareholders deficit worsened to $(5,836,329) as of June 30, 2025, from $(5,554,782) at December 31, 2024.
  • The deadline to complete a business combination has been extended multiple times, with the current date being September 4, 2025, with potential for further extensions until December 4, 2026.
  • The company's securities were delisted from NYSE American on November 1, 2024, and are now quoted on the OTC Pink Open Market.
  • Significant redemptions of Class A ordinary shares occurred in connection with extension votes: $1,032,028,964 in February 2023, $7,662,572 in February 2024, and $15,111,008 in November 2024.
  • The Sponsor and related parties have provided significant loans and advances to the company, totaling $1,900,000 in promissory notes and working capital loans, and a $1,485,000 advance.

Sentiment

Score: 2

Explanation: The company faces severe liquidity issues, substantial doubt about its going concern ability, and has been delisted from a major exchange. While it secured extensions and underwriters waived fees, the core problem of finding a business combination remains unresolved, and significant redemptions have depleted its resources. The reliance on related party funding underscores its precarious position.

Positives

  • Net income of $240,199 for the three months ended June 30, 2025, reversing a loss trend, primarily due to a change in fair value of warrant liabilities.
  • General and administrative expenses decreased significantly to $138,996 for Q2 2025 from $272,570 for Q2 2024, and to $281,547 for 6M 2025 from $906,450 for 6M 2024.
  • The company successfully secured multiple extensions for its business combination deadline, providing more time to find a target.
  • Major underwriters (BofA Securities, Goldman Sachs, Credit Suisse) waived their deferred underwriting fees, eliminating a significant liability of $36,225,000.

Negatives

  • The company reported a net loss of $267,778 for the six months ended June 30, 2025.
  • Cash on hand outside the Trust Account significantly decreased to $38,297, indicating limited operating liquidity.
  • A substantial working capital deficit of $2,819,579 as of June 30, 2025.
  • The company's securities were delisted from NYSE American and now trade on the OTC Pink Open Market, which typically implies lower liquidity and visibility.
  • Significant shareholder redemptions totaling over $1.05 billion across multiple extension votes have drastically reduced the funds available for a business combination.
  • The company relies heavily on loans and advances from related parties (Sponsor and affiliates) to fund operations and extensions, totaling $3,385,000 in outstanding related party debt and advances.

Risks

  • Substantial doubt exists about the company's ability to continue as a going concern if a business combination is not consummated by September 4, 2025 (or December 4, 2026, if all extensions are exercised).
  • Failure to complete a business combination within the specified period will result in mandatory liquidation and dissolution, leading to public warrants expiring worthless.
  • The company's operating cash of $38,297 and working capital deficit of $2,819,579 indicate insufficient liquidity to fund operations without additional financing.
  • Reliance on the Sponsor and affiliates for loans and advances to meet working capital needs, with no assurance of continued financing.
  • The delisting from NYSE American to OTC Pink Open Market may negatively impact liquidity and investor interest.
  • The impact of current global conflicts (Russia-Ukraine, Israel-Hamas) on the world economy is not determinable and could adversely affect the company's financial condition.

Future Outlook

The company intends to continue incurring significant costs in pursuit of an acquisition. It has until September 4, 2025, or potentially December 4, 2026, to consummate a business combination. Management aims to complete a business combination before the mandatory liquidation date, but there is substantial doubt about its ability to do so and to continue as a going concern without additional financing.

Management Comments

  • Management has determined that the liquidity condition raises substantial doubt about the company's ability to continue as a going concern.
  • Management intends to complete a Business Combination prior to the mandatory liquidation date.

Industry Context

This filing reflects the ongoing challenges faced by many Special Purpose Acquisition Companies (SPACs) in the current market environment. High redemption rates, difficulty in identifying suitable target businesses, and the pressure of approaching liquidation deadlines are common themes. The delisting from a major exchange like NYSE American to the OTC Pink Open Market is a typical consequence for SPACs that fail to complete a business combination within their initial timeframe, further limiting their appeal and liquidity.

Comparison to Industry Standards

  • The company's high redemption rates (over $1.05 billion across multiple votes) are significantly above industry averages for SPACs, indicating a strong lack of investor confidence in the company's ability to find a suitable target or complete a value-accretive transaction.
  • The shift from NYSE American to the OTC Pink Open Market is a clear indicator of failure to meet major exchange listing requirements, contrasting sharply with successful SPACs that complete de-SPAC transactions and maintain their listing.
  • The reliance on related party loans and advances for working capital, totaling $3.385 million, is a common characteristic of distressed SPACs struggling to cover operational expenses as their trust account funds diminish due to redemptions and lack of a definitive business combination.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Memorandum and Articles of AssociationAmended to extend the business combination termination date from December 4, 2024, to January 4, 2025, and to allow for up to twenty-three additional one-month extensions until December 4, 2026, by board resolution.2024-11-26Provides the company with significantly more time to complete a business combination, but also reflects ongoing difficulty in finding a suitable target and has led to further shareholder redemptions.

Related Party Transactions

  • Monthly fee of $10,000 paid to an affiliate of the Sponsor for office space, secretarial, and administrative services.
  • Working Capital Loan of $500,000 outstanding from the Sponsor, convertible into warrants.
  • Promissory Note (August 2023 Note) of $500,000 outstanding from the Sponsor.
  • Promissory Note (March 2024 Note) of $500,000 outstanding, initially from the Sponsor, then assigned to Starwood Capital Group Management, L.L.C.
  • Promissory Note (October 2024 Note) of $400,000 outstanding from Starwood Capital Group Management, L.L.C.
  • Advance from related parties of $1,485,000 from the Sponsor for company expenses.

Stakeholder Impact

  • Shareholders: Face significant risk of losing investment if a business combination is not completed, as public warrants will expire worthless upon liquidation. Redemptions have significantly reduced the number of outstanding public shares.
  • Sponsor/Affiliates: Have provided substantial financial support through loans and advances, indicating their continued commitment but also exposure to the company's going concern risk. They have waived rights to liquidating distributions on Founder Shares.
  • Underwriters: Waived deferred underwriting fees, indicating a loss of potential income from the IPO.

Next Steps

  • Identify and evaluate target businesses for a business combination.
  • Perform business due diligence on prospective target businesses.
  • Structure, negotiate, and complete a business combination prior to the mandatory liquidation date of September 4, 2025 (or December 4, 2026, if all extensions are exercised).
  • Potentially raise additional capital through loans or investments if a business combination is not consummated.

Key Dates

DateDescription
2020-10-19Company incorporated as a Cayman Islands exempted company.
2021-02-01Registration statement for IPO declared effective.
2021-02-04Consummation of IPO and sale of private placement warrants.
2022-02-23Company entered into a cost-sharing arrangement.
2023-01-19Company issued a convertible promissory note (working capital loan) of up to $500,000 to the Sponsor.
2023-02-01Extension meeting held; deadline to complete business combination extended from February 4, 2023, to February 4, 2024.
2023-02-14BofA Securities, Inc. notified the company of waiving its deferred underwriting fee rights.
2023-02-16Goldman Sachs & Co. LLC notified the company of waiving its deferred underwriting fee rights.
2023-08-08Company issued a promissory note (August 2023 Note) of up to $500,000 to the Sponsor and borrowed the full amount.
2023-08-14Credit Suisse Securities (USA) LLC notified the company of waiving its deferred underwriting fee rights.
2024-02-02Extension meeting held; deadline to complete business combination extended from February 4, 2024, to March 4, 2024, with monthly extension options.
2024-02-05Company received notice from NYSE American regarding delisting proceedings.
2024-02-06Sponsor converted 25,500,000 Class B ordinary shares into Class A ordinary shares.
2024-03-13Company issued a promissory note (March 2024 Note) of up to $500,000 to the Sponsor.
2024-03-14Company borrowed $125,000 under the March 2024 Note.
2024-03-28Company borrowed an additional $235,000 under the March 2024 Note.
2024-04-15Sponsor assigned the March 2024 Note to Starwood Capital Group Management, L.L.C.
2024-07-22Company borrowed an additional $140,000 under the March 2024 Note.
2024-10-02Sponsor paid $1,485,000 for company expenses; board approved $25,000 extension fund deposit, extending deadline to November 4, 2024.
2024-10-23Board approved $25,000 extension fund deposit, extending deadline to December 4, 2024.
2024-10-31Company issued a promissory note (October 2024 Note) of $400,000 to Starwood Capital Group Management, L.L.C. and borrowed the full amount.
2024-11-01NYSE American completed delisting of the company's securities.
2024-11-26Extraordinary general meeting held to amend memorandum and articles of association, extending termination date to January 4, 2025, with further monthly extension options.
2025-06-30End of the reported quarterly period.
2025-08-11Date of filing of the Quarterly Report on Form 10-Q.
2025-09-04Current business combination termination date, assuming extensions exercised.
2026-12-04Latest possible business combination termination date, assuming all extensions are exercised.

Recommendation

strong sell

The company is a distressed SPAC with a history of significant shareholder redemptions, a dwindling cash balance outside the trust, and a substantial working capital deficit. It has been delisted from a major exchange and explicitly states 'substantial doubt about the Company’s ability to continue as a going concern.' While extensions provide more time, the fundamental issue of finding a viable business combination remains unresolved, and the current financial state suggests a high probability of liquidation, which would render warrants worthless and return only the trust value per share to remaining public shareholders, likely below initial IPO price. The reliance on related party funding further highlights its precarious position. This is a highly speculative investment with significant downside risk.

Keywords

SPAC, Special Purpose Acquisition Company, Blank Check Company, Business Combination, Merger, Acquisition, Going Concern, Redemption, Warrants, Trust Account, OTC Pink Market, Financial Reporting, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.